113 related articles for article (PubMed ID: 11562197)
1. Synthesis of ring- and side-chain-substituted m-iodobenzylguanidine analogues.
Vaidyanathan G; Shankar S; Zalutsky MR
Bioconjug Chem; 2001; 12(5):786-97. PubMed ID: 11562197
[TBL] [Abstract][Full Text] [Related]
2. No-carrier-added synthesis of a 4-methyl-substituted meta-iodobenzylguanidine analogue.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Appl Radiat Isot; 2005 Mar; 62(3):435-40. PubMed ID: 15607920
[TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues.
Vaidyanathan G; Shankar S; Affleck DJ; Welsh PC; Slade SK; Zalutsky MR
Bioconjug Chem; 2001; 12(5):798-806. PubMed ID: 11562198
[TBL] [Abstract][Full Text] [Related]
4. A convenient method for the preparation of radioiodinated meta-iodobenzylguanidine at a no-carrier-added level.
Wang G; Chen Z; Wu E; Wang Y; Huang H
J Labelled Comp Radiopharm; 2015; 58(11-12):442-4. PubMed ID: 26391308
[TBL] [Abstract][Full Text] [Related]
5. [A simple and rapid routine preparation of no-carrier added meta-I-123- and I-131-iodobenzylguanidine (I-123-MIBG and I-131-MIBG) for clinical nuclear medicine applications].
Samnick S; Kirsch CM
Nuklearmedizin; 1999; 38(7):292-6. PubMed ID: 10599069
[TBL] [Abstract][Full Text] [Related]
6. Iodopyridine-for-iodobenzene substitution for use with low molecular weight radiopharmaceuticals: application to m-iodobenzylguanidine.
Vaidyanathan G; Zalutsky MR; DeGrado TR
Bioconjug Chem; 1998; 9(6):758-64. PubMed ID: 9815170
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of radioiodination of meta-iodobenzylguanidine (MIBG) catalysed by in situ generated Cu(I) and directly added Cu(II).
Prabhakar G; Mehra KS; Ramamoorthy N; Chattopadhyay S; Oommen R; Narasimhan S; Nair NA; Gunasekaran S
Appl Radiat Isot; 1999 Jun; 50(6):1011-4. PubMed ID: 10355103
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a fast and high yield method for routine production of [(131) I]MIBG and investigation of its radiochemical stability for diagnosis and treatment uses.
Davarpanah MR; Attar Nosrati S; Khoshhosn HA; Fazlali M; Kazemi Boudani M
J Labelled Comp Radiopharm; 2013 Nov; 56(13):686-8. PubMed ID: 25196031
[TBL] [Abstract][Full Text] [Related]
9. An efficient batch preparation of high specific activity.
Amartey JK; Al-Jammaz I; Lambrecht RM
Appl Radiat Isot; 2001 May; 54(5):711-4. PubMed ID: 11258518
[TBL] [Abstract][Full Text] [Related]
10. A convenient solution-phase method for the preparation of meta-iodobenzylguanidine in high effective specific activity.
Donovan AC; Valliant JF
Nucl Med Biol; 2008 Oct; 35(7):741-6. PubMed ID: 18848658
[TBL] [Abstract][Full Text] [Related]
11. A kit method for the high level synthesis of [211At]MABG.
Vaidyanathan G; Affleck DJ; Alston KL; Zhao XG; Hens M; Hunter DH; Babich J; Zalutsky MR
Bioorg Med Chem; 2007 May; 15(10):3430-6. PubMed ID: 17387017
[TBL] [Abstract][Full Text] [Related]
12. Meta-iodobenzylguanidine derivatives containing a second guanidine moiety.
Vaidyanathan G; Shankar S; Affleck DJ; Alston K; Norman J; Welsh P; LeGrand H; Zalutsky MR
Bioorg Med Chem; 2004 Apr; 12(7):1649-56. PubMed ID: 15028258
[TBL] [Abstract][Full Text] [Related]
13. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
Vaidyanathan G; Zalutsky MR
Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
[TBL] [Abstract][Full Text] [Related]
14. An alternative and expedient synthesis of radioiodinated 4-iodophenylalanine.
Vaidyanathan G; McDougald D; Grasfeder L; Zalutsky MR; Chin B
Appl Radiat Isot; 2011 Oct; 69(10):1401-6. PubMed ID: 21621415
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
16. Potential and practical adrenomedullary PET radiopharmaceuticals as an alternative to m-iodobenzylguanidine: m-(omega-[18F]fluoroalkyl)benzylguanidines.
Lee BC; Paik JY; Chi DY; Lee KH; Choe YS
Bioconjug Chem; 2004; 15(1):104-11. PubMed ID: 14733589
[TBL] [Abstract][Full Text] [Related]
17. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
Israel I; Brandau W; Farmakis G; Samnick S
Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
[TBL] [Abstract][Full Text] [Related]
18. Meta-iodobenzylguanidine and analogues: chemistry and biology.
Vaidyanathan G
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):351-68. PubMed ID: 19088690
[TBL] [Abstract][Full Text] [Related]
19. 1-(m-[211At]astatobenzyl)guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1992; 3(6):499-503. PubMed ID: 1463779
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-labeled MIBG derivatives: novel 99mTc complexes as myocardial imaging agents for sympathetic neurons.
Zhuang ZP; Kung MP; Mu M; Hou C; Kung HF
Bioconjug Chem; 1999; 10(2):159-68. PubMed ID: 10077463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
